'Primary efficacy' diaporamas de présentation

Nuevas evidencias en el tratamiento de las dislipemias

485 views • 48 slides

Medtronic RDN SYMPLICITY HTN-3 & Global SYMPLICITY Registry (GSR)

Medtronic RDN SYMPLICITY HTN-3 & Global SYMPLICITY Registry (GSR). Key Takeaways. SYMPLICITY HTN-3 did not reach the primary or powered secondary efficacy endpoints in this trial. There may be many factors that contributed to the outcome, which we continue to investigate .

671 views • 42 slides

MEMANTINE AS AN ADJUNCT IN REFRACTORY SCHIZOPHRENIA

MEMANTINE AS AN ADJUNCT IN REFRACTORY SCHIZOPHRENIA. OVERVIEW. Background: Link between glutamatergic neurotransmission and schizophrenia Overview of RCTs: Lieberman et al. Lucena et al. Implication to practice. Background.

492 views • 37 slides

Roxana Mehran, John Alexander, and Michael Lincoff

Effect of REG1 Anticoagulation System versus Bivalirudin on Cardiovascular Outcomes Following PCI: The REGULATE-PCI Randomized Clinical Trial. Roxana Mehran, John Alexander, and Michael Lincoff on the Behalf of the REGULATE-PCI Investigators. Conflicts of Interest. Consulting :

329 views • 32 slides

Roxana Mehran, John Alexander, and Michael Lincoff

Effect of REG1 Anticoagulation System versus Bivalirudin on Cardiovascular Outcomes Following PCI: The REGULATE-PCI Randomized Clinical Trial. Roxana Mehran, John Alexander, and Michael Lincoff on the Behalf of the REGULATE-PCI Investigators.

264 views • 26 slides

TAO : Treatment of Acute Coronary Syndromes with Otamixaban

351 views • 24 slides

NDA 22,062 orBec ODAC

NDA 22,062 orBec ODAC . Clinical Review - Nancy S. Scher, M.D. Biostatistical Review - Shan Sun-Mitchell, Ph.D. May 9, 2007. Project Management Frank Cross, M.A., MT (ASCP) Medical Review Nancy Scher, M.D., Medical Officer Ann Farrell, M.D. Acting Deputy Director

311 views • 13 slides

Fred D. Lublin, MD Saunders Family Professor of Neurology

Thrice-Weekly Glatiramer Acetate for Relapsing Forms of Multiple Sclerosis: Findings from the GALA Study. Krzysztof Selmaj, MD, PhD Professor of Neurology Chair, Department of Neurology Medical University of Lodz Lodz, Poland. Fred D. Lublin, MD Saunders Family Professor of Neurology

216 views • 5 slides

*Exclusion criteria n = 3816

Primary Efficacy , correct vaccine n=850. Primary Efficacy subgroup n = 856. MnCC n=429. MnCC n=409. PnCRM7 n=421. PnCRM7 n=394. PnCRM7 n=424. MnCC n=432.

147 views • 1 slides